Titan Medical announced that the United States Patent and Trademark Office, USPTO recently issued patent No. 11,504,191, titled "Graphical User Interface for a Robotic Surgical System." The patent, directed at enhancing the surgeon user experience, generally covers a graphical user interface overlay of a surgical workspace to track instrument movement. "The granting of this patent is a result of our strategic plan to independently build and protect a robust patent portfolio in robotic assisted surgery, including around the Enos robotic single access surgical system. Today’s news validates our commitment to the continuum of innovation in robotic assisted surgery," stated Cary Vance, President, and CEO of Titan. "Along with recent patent application filings, including some that have recently published, this patent demonstrates the company’s focus on being an innovation leader in single-access RAS. The technology covered in this patent could assist with early-stage artificial intelligence that works to limit movement of instruments, including movements based on patient anatomy or more general keep-out zones, as well as enhancements in single-access RAS beyond the Enos system, including next generation single-access RAS technologies and systems. We believe the breadth and depth of our patent portfolio provides us with options for monetization or other strategic opportunities." The granted patent covers technology that generates a three-dimensional boundary for instruments within the surgical workspace, based on movement generated by a user-controlled hand controller.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TMDI:
- Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery
- Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process
- Titan Medical suspends special meeting of shareholders
- Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process
- Titan Medical U.S. subsidiary temporarily furloughs 40 employees